CN Patent

CN101919810A — 一种右泛醇输液制剂及其制备方法

Assigned to HEBEI KAISHENG MEDICAL TECHNOLOGY Co Ltd · Expires 2010-12-22 · 15y expired

What this patent protects

本发明公开了一种右泛醇输液制剂及其制备方法，该输液由活性成分右泛醇与一定pH值的等渗溶剂经高温灭菌制备而成。新剂型的研制成功解决了药物使用过程中二次污染问题，使右泛醇的临床应用更加安全、高效和方便。该输液作为预防剂，可减少较大腹部外科手术后发生麻痹性肠梗阻的可能性，可用于肠无力导致的腹胀，术后或产后肠胃气，或者肠能动性恢复的术后延迟等。

USPTO Abstract

本发明公开了一种右泛醇输液制剂及其制备方法，该输液由活性成分右泛醇与一定pH值的等渗溶剂经高温灭菌制备而成。新剂型的研制成功解决了药物使用过程中二次污染问题，使右泛醇的临床应用更加安全、高效和方便。该输液作为预防剂，可减少较大腹部外科手术后发生麻痹性肠梗阻的可能性，可用于肠无力导致的腹胀，术后或产后肠胃气，或者肠能动性恢复的术后延迟等。

Drugs covered by this patent

Patent Metadata

Patent number
CN101919810A
Jurisdiction
CN
Classification
—
Expires
2010-12-22
Drug substance claim
No
Drug product claim
No
Assignee
HEBEI KAISHENG MEDICAL TECHNOLOGY Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.